Literature DB >> 8596143

Human T-cell leukemia virus type I tax transactivates the interleukin-6 gene in human rheumatoid synovial cells.

N Mori1, F Shirakawa, M Abe, Y Kamo, Y Koyama, S Murakami, H Shimizu, K Yamamoto, S Oda, S Eto.   

Abstract

OBJECTIVE: To determine the effect of the human T cell leukemia virus type I (HTLV-I) tax gene on interleukin-6 (IL-6) production and gene transcription in synovial cells, we established the synovial cell line, E-11, from a patient with rheumatoid arthritis.
METHODS: E-11 cells were transfected with tax expression vector using the calcium phosphate coprecipitation method. IL-6 production and gene expression were investigated by ELISA and Northern blot analysis, respectively. To clarify how tax induces IL-6 gene expression, we used deletion analysis and chloramphenicol acetyltransferase (CAT) assay, and electrophoretic mobility shift assay (EMSA).
RESULTS: Transfection of the tax gene induced markedly high levels of IL-6 mRNA. Furthermore, the tax gene strongly transactivated IL-6 gene promoter activity assayed by CAT assay. By using deletion and site specific mutations, we have identified a nuclear factor (NF)-kappa B sequence (positions -73 to -63) which is essential for tax transaction. EMSA demonstrated the induction of specific binding of nuclear extracts to the NF-kappa B sequence by HTLV-I tax.
CONCLUSION: The HTLV-1 tax gene may transactivate IL-6 gene in the synovial cells through NF-kappa B and may contribute in the pathophysiology of HTLV-I associated arthritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8596143

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome.

Authors:  M G Toporkova; S E Aleshin; S V Ozherelkov; M V Nadezhdina; J R Stephenson; A V Timofeev
Journal:  Clin Exp Immunol       Date:  2008-06       Impact factor: 4.330

3.  Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy.

Authors:  Chihiro Iwao; Kunihiko Umekita; Shunichi Miyauchi; Masatoshi Kimura; Yuki Rikitake; Koushou Iwao; Mao Rikitake; Ayako Aizawa; Takeshi Kawaguchi; Yumi Kariya; Motohiro Matsuda; Ichiro Takajo; Kazutaka Shiomi; Akihiko Okayama
Journal:  Intern Med       Date:  2020-04-23       Impact factor: 1.271

4.  Altered expression of inflammatory cytokines in primary osteoarthritis by human T lymphotropic virus type I retrovirus infection: a cross-sectional study.

Authors:  Yoshiki Yoshihara; Tomoo Tsukazaki; Makoto Osaki; Masahiro Nakashima; Kazuhisa Hasui; Hiroyuki Shindo
Journal:  Arthritis Res Ther       Date:  2004-06-07       Impact factor: 5.156

Review 5.  Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses.

Authors:  J Hiscott; T-L A Nguyen; M Arguello; P Nakhaei; S Paz
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.